Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-02-14 1:49 pm Purchase | 13G | ARDELYX INC ARDX | Rock Springs Capital Management LP | 4,990,187 6.01% | 1,807,390 (+56.79%) | View |
2020-02-14 1:49 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Rock Springs Capital Management LP | 1,500,000 4.66% | 200,000 (+15.38%) | View |
2020-02-14 1:49 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,245,000 5.42% | -155,000 (-11.07%) | View |
2020-02-14 1:49 pm Sale | 13G | PHASEBIO PHARMACEUTICALS INC C PHAS | Rock Springs Capital Management LP | 1,125,000 3.91% | -325,000 (-22.41%) | View |
2019-12-16 1:00 pm Purchase | 13G | MIRUM PHARMACEUTICALS INC MIRM | Rock Springs Capital Management LP | 1,400,000 6.09% | 1,400,000 (New Position) | View |
2019-10-11 4:10 pm Purchase | 13G | APREA THERAPEUTICS INC APRE | Rock Springs Capital Management LP | 925,000 4.46% | 925,000 (New Position) | View |
2019-10-07 4:19 pm Purchase | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Rock Springs Capital Management LP | 1,300,000 5.06% | 1,300,000 (New Position) | View |
2019-09-27 12:06 pm Purchase | 13G | ARDELYX INC ARDX | Rock Springs Capital Management LP | 3,182,797 5.06% | 1,042,610 (+48.72%) | View |
2019-07-29 4:33 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Rock Springs Capital Management LP | 2,100,000 5.09% | 2,100,000 (New Position) | View |